Cargando…
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as d...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393413/ https://www.ncbi.nlm.nih.gov/pubmed/36826230 http://dx.doi.org/10.1093/brain/awad044 |
_version_ | 1785083152145842176 |
---|---|
author | Rahayel, Shady Tremblay, Christina Vo, Andrew Misic, Bratislav Lehéricy, Stéphane Arnulf, Isabelle Vidailhet, Marie Corvol, Jean-Christophe Gagnon, Jean-François Postuma, Ronald B Montplaisir, Jacques Lewis, Simon Matar, Elie Ehgoetz Martens, Kaylena Borghammer, Per Knudsen, Karoline Hansen, Allan K Monchi, Oury Gan-Or, Ziv Dagher, Alain |
author_facet | Rahayel, Shady Tremblay, Christina Vo, Andrew Misic, Bratislav Lehéricy, Stéphane Arnulf, Isabelle Vidailhet, Marie Corvol, Jean-Christophe Gagnon, Jean-François Postuma, Ronald B Montplaisir, Jacques Lewis, Simon Matar, Elie Ehgoetz Martens, Kaylena Borghammer, Per Knudsen, Karoline Hansen, Allan K Monchi, Oury Gan-Or, Ziv Dagher, Alain |
author_sort | Rahayel, Shady |
collection | PubMed |
description | Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson’s disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49–87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41–88) years; 77% men] with T(1)-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain’s structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer’s disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain’s structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer’s disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks. |
format | Online Article Text |
id | pubmed-10393413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103934132023-08-02 Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies Rahayel, Shady Tremblay, Christina Vo, Andrew Misic, Bratislav Lehéricy, Stéphane Arnulf, Isabelle Vidailhet, Marie Corvol, Jean-Christophe Gagnon, Jean-François Postuma, Ronald B Montplaisir, Jacques Lewis, Simon Matar, Elie Ehgoetz Martens, Kaylena Borghammer, Per Knudsen, Karoline Hansen, Allan K Monchi, Oury Gan-Or, Ziv Dagher, Alain Brain Original Article Isolated rapid eye movement sleep behaviour disorder (iRBD) is a sleep disorder characterized by the loss of rapid eye movement sleep muscle atonia and the appearance of abnormal movements and vocalizations during rapid eye movement sleep. It is a strong marker of incipient synucleinopathy such as dementia with Lewy bodies and Parkinson’s disease. Patients with iRBD already show brain changes that are reminiscent of manifest synucleinopathies including brain atrophy. However, the mechanisms underlying the development of this atrophy remain poorly understood. In this study, we performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed iRBD patients [67.7 ± 6.6 (49–87) years; 83% men] and 238 healthy controls [66.6 ± 7.9 (41–88) years; 77% men] with T(1)-weighted MRI to investigate the gene expression and connectivity patterns associated with changes in cortical thickness and surface area in iRBD. Partial least squares regression was performed to identify the gene expression patterns underlying cortical changes in iRBD. Gene set enrichment analysis and virtual histology were then done to assess the biological processes, cellular components, human disease gene terms, and cell types enriched in these gene expression patterns. We then used structural and functional neighbourhood analyses to assess whether the atrophy patterns in iRBD were constrained by the brain’s structural and functional connectome. Moreover, we used comprehensive spatial mapping analyses to assess the specific neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems associated with cortical changes in iRBD. All comparisons were tested against null models that preserved spatial autocorrelation between brain regions and compared to Alzheimer’s disease to assess the specificity of findings to synucleinopathies. We found that genes involved in mitochondrial function and macroautophagy were the strongest contributors to the cortical thinning occurring in iRBD. Moreover, we demonstrated that cortical thinning was constrained by the brain’s structural and functional connectome and that it mapped onto specific networks involved in motor and planning functions. In contrast with cortical thickness, changes in cortical surface area were related to distinct genes, namely genes involved in the inflammatory response, and to different spatial mapping patterns. The gene expression and connectivity patterns associated with iRBD were all distinct from those observed in Alzheimer’s disease. In summary, this study demonstrates that the development of brain atrophy in synucleinopathies is constrained by specific genes and networks. Oxford University Press 2023-02-24 /pmc/articles/PMC10393413/ /pubmed/36826230 http://dx.doi.org/10.1093/brain/awad044 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Rahayel, Shady Tremblay, Christina Vo, Andrew Misic, Bratislav Lehéricy, Stéphane Arnulf, Isabelle Vidailhet, Marie Corvol, Jean-Christophe Gagnon, Jean-François Postuma, Ronald B Montplaisir, Jacques Lewis, Simon Matar, Elie Ehgoetz Martens, Kaylena Borghammer, Per Knudsen, Karoline Hansen, Allan K Monchi, Oury Gan-Or, Ziv Dagher, Alain Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
title | Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
title_full | Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
title_fullStr | Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
title_full_unstemmed | Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
title_short | Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
title_sort | mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393413/ https://www.ncbi.nlm.nih.gov/pubmed/36826230 http://dx.doi.org/10.1093/brain/awad044 |
work_keys_str_mv | AT rahayelshady mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT tremblaychristina mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT voandrew mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT misicbratislav mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT lehericystephane mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT arnulfisabelle mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT vidailhetmarie mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT corvoljeanchristophe mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT gagnonjeanfrancois mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT postumaronaldb mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT montplaisirjacques mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT lewissimon mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT matarelie mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT ehgoetzmartenskaylena mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT borghammerper mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT knudsenkaroline mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT hansenallank mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT monchioury mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT ganorziv mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT dagheralain mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies AT mitochondrialfunctionassociatedgenesunderliecorticalatrophyinprodromalsynucleinopathies |